Company intelligence / Profile preview

OMID Holdings

Alpha, New Jersey, United States

Ownership: Private
Employees: ~10
Development stage: Other

Overview

OMID Holdings is a publicly traded health and wellness company focused on developing, manufacturing, and selling CBD-based and other herbal wellness products. The company operates an FDA-registered, GMP-certified manufacturing facility in Alpha, New Jersey and also provides private-label manufacturing services. Its product activity appears centered on consumer wellness formulations containing cannabis extracts rather than a traditional therapeutic drug pipeline. Based on available public information, OMID is better characterized as a cannabinoid wellness and manufacturing company than a clinical-stage biotech or pharmaceutical developer.

Modalities: Small molecule
Industry: Food & Nutrition

Beyond the preview

Go deeper on OMID Holdings.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on OMID Holdings.

Explore the full profile